<?xml version="1.0" encoding="UTF-8"?>
<urlset xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
		xsi:schemaLocation="http://www.sitemaps.org/schemas/sitemap/0.9 http://www.sitemaps.org/schemas/sitemap/0.9/sitemap.xsd"
		xmlns="http://www.sitemaps.org/schemas/sitemap/0.9"
		xmlns:news="http://www.google.com/schemas/sitemap-news/0.9"
		xmlns:image="http://www.google.com/schemas/sitemap-image/1.1"><url>
				<loc>https://beta-develop.veja.abril.com.br/coluna/letra-de-medico/cancer-de-ovario-os-exames-que-estao-redefinindo-o-tratamento/</loc>
				<image:image>
					<image:loc>https://beta-develop.veja.abril.com.br/wp-content/uploads/2016/05/sindrome-dos-ovarios-barriga-mulher-original3.jpeg?quality=70&#038;strip=info</image:loc>
				</image:image></url><url>
				<loc>https://beta-develop.veja.abril.com.br/coluna/planeta-ia/a-farmaceutica-que-virou-referencia-mundial-em-ia-sem-querer-ficar-rica/</loc>
				<image:image>
					<image:loc>https://beta-develop.veja.abril.com.br/wp-content/uploads/2026/07/Ana-Helena-NoHarm.jpg?quality=70&#038;strip=info</image:loc>
				</image:image></url></urlset>